Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4743 results found.

Example of search result explained

M-Tranexamic Acid

Covered
  • Active ingredient(s):
    tranexamic acid
  • Manufactured by:
    Mantra Pharma inc. (Mantra Ph.)
  • Strength and dosage form:
    Tablet 500 mg DIN : 2549395

Chlorhydrate de vancomycine pour injection

Covered
  • Active ingredient(s):
    vancomycin hydrochloride
  • Manufactured by:
    Hikma Canada Limited (Hikma)
  • Strength and dosage form:
    • Intravenous or Perfusion Powder 1 g DIN : 2543982
    • Intravenous or Perfusion Powder 500 mg DIN : 2543974

Nat-Abiraterone

Exceptional medication

Hadlima PushTouch (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114437
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114435

Hadlima (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (ulcerative colitis-children)
  • Manufactured by:
    Organon Canada Inc. (Organon)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114436
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114434

Mar-Afatinib

Exceptional medication
  • Active ingredient(s):
    afatinib dimaleate
  • Manufactured by:
    Marcan Pharmaceuticals Inc. (Marcan)
  • Strength and dosage form:
    • Tablet 20 mg DIN : 2517019
    • Tablet 30 mg DIN : 2517027
    • Tablet 40 mg DIN : 2517035

Bimzelx

Exceptional medication
  • Active ingredient(s):
    bimekizumab (plaque psoriasis)
  • Manufactured by:
    U.C.B. Pharma Canada Inc. (U.C.B.)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 160 mg/mL (1 mL) DIN : 2525267
    • Subcutaneous Injectable Solution syringe 160 mg /mL (2 mL) DIN : 2553619
    • Subcutaneous Injectable Solution (pen) 160 mg/mL (1 mL) DIN : 2525275
    • Subcutaneous Injectable Solution (pen) 160 mg /mL (2 mL) DIN : 2553627

JAMP Cabergoline

Exceptional medication
  • Active ingredient(s):
    cabergoline
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Tablet 0.5 mg DIN : 2549611

AG-Gliclazide MR

Covered
  • Active ingredient(s):
    gliclazide
  • Manufactured by:
    Angita Pharma Inc. (Angita)
  • Strength and dosage form:
    • Long-Action Tablet 30 mg DIN : 2483300
    • Long-Action Tablet 60 mg DIN : 2483319

Ixifi

Exceptional medication
  • Active ingredient(s):
    infliximab
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 100 mg DIN : 2523191
Page 465 of 475

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.